The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis

Shock

Volumn 35, Issue 5, 2011, Pages 499-505

  McNeal, Sam I ^a,b   Legolvan, Mark P ^a,b   Chung, Chun Shiang ^a   Ayala, Alfred ^a,b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Apoptotic versus necrotic cell death; CLP; kinase inhibition; mouse liver; RIP1 kinase; siRNA

Indexed keywords

FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NECROSTATIN 1; PHOSPHOTRANSFERASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RIP1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GLYCOGEN LIVER LEVEL; HISTOPATHOLOGY; LIVER CELL; LIVER INJURY; MALE; MORPHOLOGY; MORTALITY; MOUSE; NONHUMAN; SEPSIS;

ANIMALS; BLOTTING, WESTERN; CASPASE 3; CELLS, CULTURED; HEPATOCYTES; IMIDAZOLES; IMMUNOPRECIPITATION; INDOLES; LIVER; LIVER GLYCOGEN; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; SEPSIS;

EID: 79955531733     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31820b2db1     Document Type: Article

References (23)

1. Stanger BZ, Leder P, Lee TH, Kim E, Seed B: RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513-523, 1995.
2. Declerq W: RIP kinases at the crossroads of cell death and survival. Cell 138:229-232, 2009.
3. Silke J, Brink R: Regulation of TNFRSF and innate immune signaling complexes by TRAFs and cIAPs. Cell Death Differ 17:35-45, 2010.
4. Cho YS: Phosphorylation driven assembly of the RIP1-RIP3 complex regulated programmed necrosis and virus induced inflammation. Cell 137:1112-1123, 2009.
5. Ayala A, Evans TA, Chaudry IH: Does hepatocellular injury in sepsis involve apoptosis? J Surg Res 76:165-173, 1998. (Pubitemid 28360016)
6. Baker CC, Chaudry IH, Gaines HO, Baue AE: Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery 94:331-335, 1983. (Pubitemid 13043132)
7. Ayala A, Herdon CD, Lehman DL, Ayala CA, Chaudry IH: Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87:4261-4275, 1996. (Pubitemid 26152269)
8. Jiang X, Gregory SH, Wing EJ: Immune CD8+ T lymphocytes lyse Listeria monocytogenes-infected hepatocytes by a classical MHC class IYrestricted mechanism. J Immunol 158:287-293, 1997. (Pubitemid 127483867)
9. Wesche-Soldato DE, Chung CS, Lomas-Neira JL, Doughty LA, Gregory SH, Ayala A: In vivo delivery of caspase 8 or Fas siRNA improves the survival of septic mice. Blood 106:2295-2301, 2005. (Pubitemid 41510799)
10. Song E, Lee S-K, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J: RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9:347-351, 2003. (Pubitemid 36362792)
11. Wesche-Soldato DE, Chung CS, Gregory SH, Salazar-Mather TP, Ayala CA, Ayala A: CD8+ T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL. Am J Pathol 171:87-96, 2007. (Pubitemid 47339229)
12. Stromberg PE, Woolsey CA, Clark AT, Clark JA, Turnbull IR, McConnell KW, Chang KC, Chung CS, Ayala A, Buchman TG, et al.: CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis. FASEB J 23:1817-1825, 2009.
13. Grimm S, Stanger BZ, Leder P: RIP and FADD: two Bdeath domain[Ycontaining proteins can induce apoptosis by convergent, but dissociable, pathways. Proc Natl Acad Sci 93:10923-10927, 1996.
14. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J: Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1:489-495, 2000.
15. Vandenabeele P, Declercq W, Vanden Berghe T: Necrotic cell death and 'necrostatins': now we can control cellular explosion. Trends Biochem Sci 33:352-355, 2008.
16. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J: Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313-321, 2008. (Pubitemid 351550892)
17. Xu EA: Ubiquitin specific peptidase 21 (usb21) inhibits tumor necrosis factor a (TNFa)-induced nuclear factor kappa b (NF-kB) activation via binding to and deubiquitinating receptor interacting protein 1 (RIP1). J Biol Chem 285:969-978, 2010.
18. Zhang D-W, Shao J, Lin J, Zhang N, Lu B-Z, Lin S-C, Dong M-Q, Han J: RIP3 an energy metabolism regulator that switches TNF induced cell death from apoptosis to necrosis. Science 325:332-336, 2009.
19. Lim SY, Davidson SM, Mocanu MM, Yellon DM, Smith CC: The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore. Cardiovasc Drugs Ther 21:467-469, 2007. (Pubitemid 350231514)
20. Wertz E, Dixit VM: Regulation of death receptor signaling by the ubiquitin system. Cell Death Differ 17:14-24, 2010.
21. Vandenabeele P: The role of kinases RIP1 and RIP3 in TNF induced necrosis. Sci Signal 3(115):re4, 2010.
22. Zingarelli B, Piraino G, Hake PW, O'Connor M, Denenberg A, Fan H, Cook JA: Peroxisome proliferatorYactivated receptor % regulates inflammation via NF.B signaling in polymicrobial sepsis. Am J Pathol 177:1834-1847, 2010.
23. Criollo A: The IKK complex contributes to the induction of autophagy. EMBOJ 29:619-631, 2010.